Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

overall survival

  • You have access
    Influence of Postoperative Pneumonia on Esophageal Cancer Survival and Recurrence
    AYAKO TAMAGAWA, TORU AOYAMA, HIROSHI TAMAGAWA, MIHWA JU, KEISUKE KOMORI, YUKIO MAEZAWA, KAZUKI KANO, KEISUKE KAZAMA, MASAAKI MURAKAWA, YOSUKE ATSUMI, SHO SAWAZAKI, KENTARO HARA, MASAKATSU NUMATA, TSUTOMU SATO, NORIO YUKAWA, MUNETAKA MASUDA and YASUSHI RINO
    Anticancer Research May 2019, 39 (5) 2671-2678; DOI: https://doi.org/10.21873/anticanres.13392
  • You have access
    Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
    MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS
    Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315
  • You have access
    Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
    HIDEAKI MIYAKE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA
    Anticancer Research March 2019, 39 (3) 1391-1396; DOI: https://doi.org/10.21873/anticanres.13253
  • You have access
    Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study
    BYOUNG CHUL CHO, TOMMASO DE PAS, HARALABOS KALOFONOS, QUN WANG, RODRYG RAMLAU, YING CHENG, FABIANA VITIELLO, TANEL LAISAAR, ERIC VALLIÈRES, BARTOSZ KUBISA, SERGEY ORLOV, KEUNCHIL PARK, CHANNA DEBRUYNE and JOHAN VANSTEENKISTE
    Anticancer Research March 2019, 39 (3) 1403-1409; DOI: https://doi.org/10.21873/anticanres.13255
  • You have access
    Uptake of 18F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage
    HIDENORI SUZUKI, TSUNEO TAMAKI, MASAMI NISHIO, HOSHINO TERADA, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and NOBUHIRO HANAI
    Anticancer Research February 2019, 39 (2) 1043-1049; DOI: https://doi.org/10.21873/anticanres.13211
  • You have access
    Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
    MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA
    Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
  • You have access
    Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer
    MARTIN SVATON, MILADA ZEMANOVA, JANA SKRICKOVA, LENKA JAKUBIKOVA, VITEZSLAV KOLEK, JURAJ KULTAN, LEONA KOUBKOVA, ALZBETA BEJCKOVA, FRANTISEK SALAJKA, MICHAL HRNCIARIK, BOHUSLAV MELICHAR, DAVID VRANA, MAREK KONECNY, RENATA CHLOUPKOVA and MILOS PESEK
    Anticancer Research December 2018, 38 (12) 6771-6782; DOI: https://doi.org/10.21873/anticanres.13048
  • You have access
    Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter?
    HEINKE C. HANSEN, STEFAN JANSSEN, CATHRIN THIEME, ALEKSEJ PERLOV, STEVEN E. SCHILD and DIRK RADES
    Anticancer Research December 2018, 38 (12) 6835-6840; DOI: https://doi.org/10.21873/anticanres.13057
  • You have access
    A Matched-Pair Study Comparing Surgery Plus Neoadjuvant Radio-Chemotherapy and Surgery Alone for High Rectal Cancers
    DIRK RADES, RASMUS PEULICHE VOGELSANG, MAXI TREDER, STEFAN JANSSEN, STEVEN E. SCHILD, NIELS HENRIK HOLLÄNDER and ISMAIL GÖGENUR
    Anticancer Research December 2018, 38 (12) 6877-6880; DOI: https://doi.org/10.21873/anticanres.13063
  • You have access
    Primary Tumor Size Predicts Distant Metastasis of Mucosal Malignant Melanoma in Head and Neck
    HIDENORI SUZUKI, GAKU TAKANO, NOBUHIRO HANAI, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and YASUHISA HASEGAWA
    Anticancer Research November 2018, 38 (11) 6485-6490; DOI: https://doi.org/10.21873/anticanres.13012

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire